Positive Link Identified Between SARS-CoV-2 and Guillain-Barré
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — There is a positive association for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Guillain-Barré syndrome (GBS), and a negative association for COVID-19 vaccination and GBS, acc…
Learn MoreStudy IDs Reference Levels for Serum Neurofilament Light Chain in Youth
TUESDAY, Aug. 8, 2023 (HealthDay News) — Measures of serum neurofilament light chain (sNfL) clinically differentiate children with neurological conditions versus healthy children, according to a study published online July 28 in The Lancet Neurology….
Learn MoreAerobic Exercise Cuts Chemotherapy-Induced Peripheral Neuropathy Symptoms
WEDNESDAY, Aug. 2, 2023 (HealthDay News) — A six-month aerobic exercise intervention significantly improves self-reported chemotherapy-induced peripheral neuropathy (CIPN) among patients treated for ovarian cancer, according to a study published onli…
Learn MoreGuidelines Developed for Respiratory Management of Neuromuscular Disease
THURSDAY, March 16, 2023 (HealthDay News) — In an American College of Chest Physicians clinical practice guideline and expert panel report, published online March 13 in CHEST, recommendations are presented for the respiratory management of patients w…
Learn MoreGuidelines Developed for Respiratory Management of Neuromuscular Disease
THURSDAY, March 16, 2023 (HealthDay News) — In an American College of Chest Physicians clinical practice guideline and expert panel report, published online March 13 in CHEST, recommendations are presented for the respiratory management of patients w…
Learn MoreGuidelines Developed for Respiratory Management of Neuromuscular Disease
THURSDAY, March 16, 2023 (HealthDay News) — In an American College of Chest Physicians clinical practice guideline and expert panel report, published online March 13 in CHEST, recommendations are presented for the respiratory management of patients w…
Learn MoreFDA Approves First Treatment for Rett Syndrome
TUESDAY, March 14, 2023 (HealthDay News) – The U.S. Food and Drug Administration has approved Daybue (trofinetide) for the treatment of Rett syndrome in adult and pediatric patients aged 2 years and older.Approval was based on results from the phase 3…
Learn MoreAAN: Spinal Cord Stimulation Beneficial for Diabetic Neuropathy
WEDNESDAY, March 1, 2023 (HealthDay News) — Spinal cord stimulation (SCS) provides pain relief and neurological improvement for patients with painful diabetic neuropathy (PDN), according to a study scheduled for presentation at the upcoming annual me…
Learn MoreNeighborhood Socioeconomic Status Tied to Mortality for Neurologic Conditions
WEDNESDAY, Feb. 15, 2023 (HealthDay News) — Neighborhood socioeconomic status (SES) is associated with 30-day mortality for common neurologic conditions, according to a study published online Feb. 15 in Neurology.Jay B. Lusk, from the Duke University…
Learn MoreDifelikefalin Improves Itch Intensity in Notalgia Paresthetica
THURSDAY, Feb. 9, 2023 (HealthDay News) — Oral treatment with difelikefalin results in greater reductions in itch intensity scores than placebo among patients with notalgia paresthetica, but it does not improve secondary outcomes, according to a stud…
Learn More